Semaglutide + BPC-157 is a medication that mimics the hormone glucagon-like peptide-1 (GLP-1) and targets areas of the brain that regulate appetite and food intake. The drug was first used to help control blood sugar levels in people with diabetes and has since been used for weight loss.

Semaglutide + BPC-157 works by slowing down the rate at which your stomach empties food and by blocking a hormone that causes your liver to release sugar. This helps you feel less hungry and eat less, leading to weight loss.

At AD Precision Health, our 8-12 week Semaglutide + BPC-157 Peptide Weight Loss Program includes:

Initial intake session and comprehensive blood panel Semaglutide + BPC-157 in either troche or injection form A doctor-designed and supervised weight loss protocol and healthy weight management plan with weekly monitoring, based on your individual weight loss needs Nutritional guides

Patients usually start Semaglutide + BPC-157 at a low dose and gradually increase to the full dose. The medication should be taken with a small sip of water (not exceeding 4 ounces) and swallowed whole. Wait at least 30 minutes after taking the medication before eating or drinking anything. It is recommended to eat a small, healthy meal 30 to 60 minutes after taking Semaglutide + BPC-157 and to take the pill at the same time and in the same manner every day. Follow all instructions provided by your healthcare provider.

Common side effects of Semaglutide + BPC-157 include nausea, diarrhea, and fatigue. Nausea is the most common side effect, with up to 20% of patients experiencing it, especially when taking the higher dose for weight loss. Diarrhea is also common, with around 20% of patients reporting this side effect. Fatigue affects about 11% of patients using Semaglutide + BPC-157 for weight loss. If you experience severe stomach pain or pain that radiates to your back, seek immediate medical attention.

At AD Precision Health, we offer a Semaglutide + BPC-157 Peptide Weight Loss Program to help our patients achieve their weight loss goals. The program uses the medication Semaglutide + BPC-157, which has been approved by the USDA for chronic weight management and has shown promising results in clinical trials.

Studies indicate that Semaglutide + BPC-157 can be effective for weight loss. In one trial, participants using Semaglutide + BPC-157 lost an average of 12.4% more of their initial body weight compared to those taking the placebo. Another study showed that 86.4% of participants who received Semaglutide + BPC-157 lost more than 5% of their body weight, compared to just 31.1% of those on the placebo.

The Semaglutide + BPC-157 Peptide Protocol at AD Precision Health combines the medication with other lifestyle changes to promote weight loss and improve overall health. The protocol has several benefits, including reducing inflammation, improving insulin resistance, lowering the risk of cardiac events, and helping control food cravings.

It's important to remember that weight loss takes time and combining the medication with a healthy diet and exercise is key to seeing the best results. Our team at AD Precision Health will work with you to determine the best plan for your individual needs and goals.